{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-058837","form_type":"8-K/A","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2025-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.899586+00:00","generated_at":"2026-05-23T05:51:32.890556+00:00","sec_items":["3.02","1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Jaguar Health extends note maturity to July 2025, reduces royalty balance by $1.09M via stock","bullets":["Issued 1,290,000 shares to a royalty holder in exchange for $1,094,952 reduction in outstanding royalty balance.","Entered Note Amendment with Streeterville Capital extending $6,220,812.50 secured promissory note maturity to July 20, 2025.","Note Amendment dated January 29, 2025, includes wholly-owned subsidiary Napo Pharmaceuticals as co-borrower.","Shares issued in the exchange rely on Section 3(a)(9) exemption from registration."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-058837","json":"https://secwatch.observer/filing/0000950170-25-058837.json","markdown":"https://secwatch.observer/filing/0000950170-25-058837.md","text":"https://secwatch.observer/filing/0000950170-25-058837.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000095017025058837/0000950170-25-058837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000095017025058837/jagx-20250129.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T05:51:32.890556+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}